@zhaoweiasu @MJMitchell_Lab @CellStemCell @rohan_palanki @lexandrePoirier Thank you! Yes-working on common skin diseases like eczema already. Prime editing is also planned. Many future applications for this :)
English
Dr. Sarah Hedtrich
279 posts
Dr. Sarah Hedtrich
@HedtrichLab
Prof@SBME@UBC, mom of 2, interested in next-generation therapies, nanomedicine & tissue engineering. Posts are my own. Advocate for #WomenInScience
Vancouver, BC, Canada Katılım Eylül 2020
185 Takip Edilen715 Takipçiler
@MJMitchell_Lab @CellStemCell @rohan_palanki @lexandrePoirier @HedtrichLab Very cool! Any plans to try other, more common skin diseases, or to use prime editing as well?
English
Dr. Sarah Hedtrich retweetledi
Check out our latest @CellStemCell led @MJMitchell_Lab Postdocs @rohan_palanki @lexandrePoirier and PhD student Emily Fitzgerald on @HedtrichLab’s laser-assisted topical LNP delivery for base editing of the skin!
Preview: doi.org/10.1016/j.stem…
Article: doi.org/10.1016/j.stem…
English
Super proud of this work from my lab that has great translational potential and can fundamentally change how we treat skin diseases.
UBC Media Relations@UBCNews
UBC researchers have developed the first gene-editing treatment for skin conditions. Safe, scalable and easy to apply topically, explore how the gene therapy could transform the treatment of skin disorders: news.ubc.ca/2026/01/first-…
English
Dr. Sarah Hedtrich retweetledi
UBC researchers have developed the first gene-editing treatment for skin conditions.
Safe, scalable and easy to apply topically, explore how the gene therapy could transform the treatment of skin disorders: news.ubc.ca/2026/01/first-…
English
Dr. Sarah Hedtrich retweetledi
Lung tissue-optimized gene editing in human cystic fibrosis models following topical application of lipid nanoparticles.
| Sarah Hedtrich @ubcpharmacy | @HedtrichLab
[Open Access]
#GeneEditing #LipidNanoparticle #transmucosal #CysticFibrosis
kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
English
I’m excited to speak at Nature Conferences this October. Join me and fellow researchers from across various disciplines to discuss insights on in vitro disease models and tissue engineering. Great line up of speakers! Abstract submissions welcome. 👉 go.nature.com/43xmvlH
English
🚨👩🔬👨🔬🧪My lab is still looking for a postdoc to develop gene editing therapies for genetic skin diseases in beautiful Vancouver! If you like great science and the outdoors, this is the place to be: ubc.wd10.myworkdayjobs.com/en-US/ubcfacul…
English
Join us in Belgrade 📌
Nature Reviews Bioengineering@natrevbioeng
Do not miss our Nature Conference 'Engineered models of human disease' this October in Belgrade, Serbia, featuring @TheLutolfLab @GVNlab @Dr_ASingh @Knoblich_lab @HedtrichLab @CJStewart7 Margherita Turco Seung-Woo Cho and more! Sign up here: go.nature.com/41isWrM
English
📢My UBC lab is recruiting two postdocs: (1) focus on topically applicable gene therapies to rescue severe skin diseases, (2) bioengineering of complex human-based models harnessing organ-on-a-chip technology: @UBC
(1) lnkd.in/dvcGqWaE
(2) lnkd.in/dmYCA74K
English
Dr. Sarah Hedtrich retweetledi
Together with @HedtrichLab we co-edited a special issue @ADDReditors about dermal drug delivery. Dont miss to read our Editorial, highlighting all the contributions to the issue. Thanks to all authors and to @krishansheora14 for designing the figure.
Link: kwnsfk27.r.eu-west-1.awstrack.me/L0/https:%2F%2…
English
@glyconet_nce @HlthResearchBC Thanks @glyconet_nce and @HlthResearchBC for funding this important research!
English
We're proud to partner with @HlthResearchBC to support several BC researchers. Partnerships are integral to our mission of advancing #glycomics and #health. Together we accelerate discoveries that shape tomorrow.
Michael Smith Health Research BC@HlthResearchBC
We’re excited to join forces with @glyconet_nce to tackle unmet health needs through glycomics research. Read more about our $2.3M investment in BC: bit.ly/3VDrNZJ
English
English
Nice visit to my home town Novi Sad Serbia last week at a brand new @BioSenseRS Biosense Institute @ivanagadjanski @crnojevic
English
Dr. Sarah Hedtrich retweetledi
Happy to share our latest publication in @WileyVCH, @AdvSciNews about #nanogels for mucosal drug delivery. Congrats @JakesUdabe et al for the excellent work and @alaromaine, @HedtrichLab for the collaboration!
@POLYMAT_BERC, @Ikerbasque, @ehu_kimika
onlinelibrary.wiley.com/doi/10.1002/ad…
English
Excellent opportunity at a great university!
Eric Jan@EricJanLab
University of British Columbia Recruitment ALERT! UBC Faculty position in Nucleic Acid Based Nanomedicine — Associate Professor or Professor | Departments of Biochemistry & Molecular Biology and Chemical & Biological Engineering. For application details: tinyurl.com/UBCNanomedicin…
English
Dr. Sarah Hedtrich retweetledi
We’re looking for a postdoc to lead an exciting new collaborative project with @WilliamsLab_UBC! The focus is on studying the dynamics of immune cell glycosylation in the tumor microenvironment. See posting for more details. Please like and RT! grad.ubc.ca/ad/58149
English
English
Very happy to receive a #LeonardoGrant of @FundationBBVA! A great milestone for our group and our institute.
@Polymat_BERC, @Ikerbasque, @ehu_kimika
English
Join! A must see for OoC and bioengineering folks!
Max Delbrück Center@MDC_Berlin
Organ-on-a-chip technologies can serve as models of #HumanBiology. @milicaruoft will begin a 3⃣-year stint at #mdcBerlin to take on the challenge of growing them with #vasculature. Join us for her MDC-Lecture "Engineering Vascularized Organs-on-a-Chip" 👇 mdc-berlin.de/news/events/mi…
English
To verify its efficacy & safety, we developed an entirely human-based atopic diseases drug discovery platform which also has a wide application range in the context of atopic diseases. Congratulations to all collaborators & particularly Partho Adhikary who led this project.
English
Our paper describing the development of the very first small molecule inhibitor of TSLP is out in @EmboMolMed : lnkd.in/d9Q3BP36
TSLP is a key driver of atopic diseases & and our highly effective anti-TSLP compound can pave the way to novel anti-inflammatory treatments.
English